mu-1 opioid receptor stimulation decreases body temperature in conscious, unrestrained neonatal rats.
The influence of mu-selective opioid agonists on neonatal thermoregulatory mechanisms has received little attention. Opioid treatment in adult subjects can cause either hyper- or hypothermia, depending on the experimental conditions, the strain of rat used, and the dose and route of administration of the drug. The present study assessed the effect of two mu opioid agonists on body temperature in neonatal Wistar rats aged 2 to 13 days. Rat pups were administered either saline or one of the two mu-selective opioid agonists, dermorphin (0.4 mg/kg) or fentanyl (0.06 mg/kg), by subcutaneous injection. Continuous rectal temperatures were measured both prior to and following drug or saline injection in freely moving, conscious animals. Ambient temperature in a plethysmograph chamber was maintained within or close to the thermoneutral zone for pups (32 degrees C). To distinguish between mu-1 and mu-2 effects, all animals received either saline or 10 mg/kg of the irreversible mu-1 antagonist naloxonazine (NALZ) 1 day prior to agonist administration. NALZ on its own had no effect on body temperature. Dermorphin and fentanyl both caused a fall in body temperature in pups of all age groups. The temperature decreases ranged from 0.8 degrees -2.2 degrees C. These opioid-induced changes were inhibited by NALZ pretreatment. Although there was no evidence for endogenous mu-1 opioid activity, this study indicated that stimulation of mu-1 opioid receptors causes a decrease in body temperature in conscious, unrestrained neonatal rats under or close to thermoneutral conditions.
Colman
Atalie S
AS
School of Biological Sciences, Victoria University of Wellington, Wellington, New Zealand.
Miller
John H
JH
D000701:Analgesics, Opioid / Q000494:pharmacology; D000818:Animals; D000831:Animals, Newborn; D001831:Body Temperature / Q000187:drug effects*; D005260:Female; D005283:Fentanyl / Q000494:pharmacology; D008297:Male; D009270:Naloxone / Q000031:analogs & derivatives* / Q000494:pharmacology; D009842:Oligopeptides / Q000494:pharmacology; D018847:Opioid Peptides; D051381:Rats; D017208:Rats, Wistar; D017450:Receptors, Opioid, mu / Q000378:metabolism* / Q000502:physiology*; D013696:Temperature; D013997:Time Factors
D000701:Analgesics, Opioid; D009842:Oligopeptides; D018847:Opioid Peptides; D017450:Receptors, Opioid, mu; C030058:dermorphin; D009270:Naloxone; C034643:naloxonazine; D005283:Fentanyl